News
Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...
After facing an unexpected regulatory delay last month, KalVista Pharmaceuticals has leapt into the commercial realm with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results